IL-21 repairs immune function in primate model of HIV infection

November 09, 2015

Antiretroviral drugs can suppress HIV for years, but a residual inflammatory imbalance contributes to health problems in infected individuals who are infected with the virus. A novel combination treatment aimed at repairing the immune system has shown encouraging effects in a nonhuman primate model of HIV infection, both during and after a course of antiretroviral drug treatment.

The results are scheduled for publication in Journal of Clinical Investigation on November 9, 2015.

Scientists at Yerkes National Primate Research Center, Emory University, were testing the effects of a fusion protein based on the immunity stimulator IL-21. They found that when combined with antiretroviral drugs, IL-21 could help restore certain types of intestinal immune cells, which are depleted by SIV (simian immunodeficiency virus) infection and thought to be important for mucosal integrity.

IL-21 has been tested in clinical trials with people fighting skin and kidney cancer, but, so far, not in people who have HIV infection.

"We found IL-21 is effective at reducing residual inflammation and improving the reconstitution of Th17 and Th22 cells, which are critical for intestinal immunity," says senior author Mirko Paiardini, PhD, assistant professor of pathology and laboratory medicine at Yerkes National Primate Research Center, Emory Vaccine Center and Emory University School of Medicine.

Co-first authors of the paper are postdoctoral fellow Luca Micci, PhD, and research specialist Emily Ryan.

In the study, the researchers treated SIV-infected rhesus macaques with the IL-21 fusion protein starting two months after they were infected. All 16 monkeys, eight IL-21-treated and eight controls, received a combination of antiretroviral drugs.

Antiretroviral drug treatment continued for seven months and then was withdrawn. IL-21 was given in three once-per-week cycles, including one cycle just after antiretroviral drugs were stopped.

After drugs were stopped, SIV still reappeared in both the IL-21-treated group and controls. However, in IL-21-treated animals, levels of SIV RNA in the blood stayed at a level that was five times less than in controls, extending out to eight months. A similar effect was seen on viral DNA levels in intestinal tissues and blood CD4 T cells. In addition, IL-21 treatment appeared to have other benefits, in terms of both reduced immune activation and signs of improved antimicrobial immunity.

"This was an important test of the concept that an intervention that reduces immune activation during antiretroviral therapy can also limit viral persistence," Paiardini says. "Our data provide a rationale for additional preclinical studies on IL-21, as part of a novel combination strategy aimed at limiting the size of the latent viral reservoir and contributing to a remission or functional cure."
Yerkes research collaborators for this study included Guido Silvestri, MD, chief of microbiology and immunology, and Francois Villinger, DVM, PhD, chief of pathology. Additional collaborators included Jacob Estes and Jeffrey Lifson, AIDS Cancer Virus Program, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc.; Jason Brenchley, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health; and Nicolas Chomont and Rémi Fromentin, Department of Microbiology, Infectiology, and Immunology, Université de Montréal, Faculty of Medicine, and Centre de Recherche du CHUM, Montreal.

The research was supported by amfAR - the Foundation for AIDS Research, the National Institute Of Allergy aAnd Infectious Diseases (R01AI084836, R01AI110334, and R33AI104278), the Emory Center for AIDS Research and the NIH Director's Office of Research Infrastructure Programs (Primate centers: P51OD011132).

Emory Health Sciences

Related Immune System Articles from Brightsurf:

How the immune system remembers viruses
For a person to acquire immunity to a disease, T cells must develop into memory cells after contact with the pathogen.

How does the immune system develop in the first days of life?
Researchers highlight the anti-inflammatory response taking place after birth and designed to shield the newborn from infection.

Memory training for the immune system
The immune system will memorize the pathogen after an infection and can therefore react promptly after reinfection with the same pathogen.

Immune system may have another job -- combatting depression
An inflammatory autoimmune response within the central nervous system similar to one linked to neurodegenerative diseases such as multiple sclerosis (MS) has also been found in the spinal fluid of healthy people, according to a new Yale-led study comparing immune system cells in the spinal fluid of MS patients and healthy subjects.

COVID-19: Immune system derails
Contrary to what has been generally assumed so far, a severe course of COVID-19 does not solely result in a strong immune reaction - rather, the immune response is caught in a continuous loop of activation and inhibition.

Immune cell steroids help tumours suppress the immune system, offering new drug targets
Tumours found to evade the immune system by telling immune cells to produce immunosuppressive steroids.

Immune system -- Knocked off balance
Instead of protecting us, the immune system can sometimes go awry, as in the case of autoimmune diseases and allergies.

Too much salt weakens the immune system
A high-salt diet is not only bad for one's blood pressure, but also for the immune system.

Parkinson's and the immune system
Mutations in the Parkin gene are a common cause of hereditary forms of Parkinson's disease.

How an immune system regulator shifts the balance of immune cells
Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.

Read More: Immune System News and Immune System Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to